Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trial

Titre

BSO - Titre

Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trial

DOI

DOI10.1016/j.diabet.2017.01.004

DOAI

DOAI10.1016/j.diabet.2017.01.004

Identifiant WoS

WOS:000418394600008

Accès ouvert

OA - Oui

Source - Accès ouvert

OA - Non

Type d'accès

Editeur

Elsevier

Source

DIABETES & METABOLISM

ISSN

1262-3636

Type de document

Article

Notoriété

3 - Correcte

CNRS

Oui

CNRS - Institut

INSB - Institut des sciences biologiques

uid:/V09RNW4M

Poids de l’Open access dans la production CNRS